Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-19

Clinical Trial Update: Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating the efficacy and safety of desvenlafaxine for vascular depression; status information is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

Sponsor: Hotel-Dieu Grace Healthcare | Conditions: Vascular Depression | Phase 4 | Status: UNKNOWN